Healthcare -
Biotechnology - NASDAQ - US
$ 1.185
-1.25 %
$ 76.1 M
Market Cap
-0.76
P/E
Price Target
Average
1137.69%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
14.29%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Inozyme Pharma, Inc.
Wall Street analysts predict an average 1-year price target for INZY of $14.7 , with forecasts ranging from
a
low of
$14 to a high of $16 .
INZY Lowest Price Target
Wall Street Target
14 USD
1081.43%
INZY Average Price Target
Wall Street Target
14.7 USD
1137.69%
INZY Highest Price Target
Wall Street Target
16 USD
1250.21%
REVENUE FORECAST
Revenue Forecast Chart INZY
EBIT FORECAST
EBIT Forecast Chart INZY
NET INCOME FORECAST
Net Income Chart INZY